Dysregulated expression of microRNAs in various tissues has been associated with a variety of diseases, including cancers (reviewed below), arthritis [31???35], neurodegenerative disorders [36???41], and cardiovascular diseases [42???49], and it has been shown that miRNA signatures can be used as novel biomarkers, potentially offering more sensitive and specific tests than those currently availabl